To study the trends in mortality over 15 years in hospitalized cancer patients with bloodstream infection.
Bacterial and fungal bloodstream infections are a frequent cause of morbidity and mortality in hospitalized patients with cancer [l] . Cancer is an independent risk factor for mortality in patients with bacteremia [2] . Several changes, which may have an effect on the outcome of these infections, have taken place over the last two decades. Some of these changes, such as the increased resistance of bacteria to antimicrobial agents [3] combined with the increased aggressivity of anticancer chemotherapy regimens, may have worsened the prognosis. Conversely, the use of new antimicrobial agents and the more frequent use of modern intensive care facilities for cancer patients [4] may have reduced the severity of the disease.
The present study was carried out to assess, over a 15-year period, the overall effect of these changes on the evolution of the morbidity and mortality associated with bacterial and fungal bloodstream infections in patients hospitalized a t the Institut Gustave-Roussy (IGR), a large 420-bed tertiary care and cancer referral center in a suburb south of Paris.
The study included all patients who had at least one positive blood culture between 1 January 1975 and 31 December 1989 while hospitalized at IGR (medicine: 38.7%; surgery: 47.3%; pediatrics: 9.8%; intensive care: 4.0%). During this period, the mean duration of hospital stay per patient decreased from 14.6 k 15.8 days in 1978 to 7.6 ? 9.5 days in 1989. By contrast, the number of hospital stays increased from 12,993 in 1978 to 23,013 in 1989.
Methodology
Throughout the study period, a set of three blood cultures was routinely drawn from all hospitalized patients with fever above 38"C, and additional blood cultures were drawn at least daily as long as the fever persisted.
Each 10to 15-mL blood sample was inoculated into two 100-mL culture bottles except in the case of children, for whom the sample volume was reduced according to their weight. From 1975 to 1 June 1982, the bottles were purchased from BioMkrieux (Marcyl'Etoile, France) and contained either brain-heart infusion broth (aseptically ventilated on arrival in the laboratory) or thioglycolate broth for aerobic and anaerobic growth, respectively. Thereafter, the bottles were purchased from Koche Diagnostic (Paris, France) and contained either brain-heart infusion broth [ventilated and adapted to a three-agar (including Sabouraud) slide system on arrival at the laboratory] or Schaedler broth for aerobic and anaerobic growth, respectively. All bottles were incubated at 37°C for 7 days, checked daily for turbidity or growth on the agar slides, and their contents subcultured. The bacteria and fungi present in the positive samples were identified using the API technique, according to the recornmendations of the manufacturer (API, La Balme-les-Grottes, France). During the period of study, the number of blood cultures performed per hospital-day increased from 0.02 in 1975 to 0.13 in 1989.
Data collection
The eligible patients were identified through the logs of the IGR's central microbiology laboratory wherein the date of each positive blood culture and name of each microorganism identified are recorded. An episode of bloodstream infection was defined as the occurrence of at least one positive blood culture in a given patient. This definition was used for all types of bloodstream infection, including those caused by coagulase-negative staphylococci (CNS) strains as, in hospitalized patients, a single blood culture positive for CNS has been found to be associated with an increased severity of the prognosis in comparison to patients with no CNS-positive cultures [5, 6] .
The characteristics of patients were obtained from the main-frame computer and, when necessary, from the individual microbiology and/or clinical records. The total number of days of hospitalization in each ward was also obtained from the main-frame computer. The original record of the microbiology data sets included 5060 episodes of bloodstream infections involving 4286 patients. However, nine staff-member patients were excluded because no permission could be obtained to see their medical records as were a further nine patients who could not be identified because of erroneous data reported in the laboratory logs. Thus, the mortality study included 5041 episodes in 4268 patients.
Two episodes were considered to be separate when different microorganisms were isolated after a period of at least 7 days, during which repeated blood cultures were negative. Different microorganisms were considered part of the same episode when they were isolated from blood samples drawn within 7 days. Nosocomial infections were those in which the first positive blood culture was drawn more than 3 days after admittance.
Description of the study population
The median age at the time of the firrt positive blood culture was 48 (range 6 months to 88) years, and the ma1e:female ratio in the population waT 1:3. The characteristics of the patients included in the study are given in Table 1 and the characteristics of the bloodstream infections in Table 2 . Most of the patients had only one episode of bloodstream infection and a single microorganism was usually isolated during each episode. About half the patients had one positive blood culture per episode. Gram-positive bacteria were isolated from more than two-thirds of the episodes and most of these were CNS strains. Gram-negative bacteria were isolated from one-third of the episodes only, and most of these belonged to the family Enterobacteriaceae. Anaerobes and yeasts were much less frequently isolated.
Statistical methods
The rates of incidence of bloodstream infections per year were obtained by taking the number of episodes occurring each year in the patients included in the study as numerators, and the total number of days of hospitalization of all patients hospitalized each year in the IGK as denominators.
The risk of death was only analyzed for the 3756 patients who had a bloodstream infection due to a single microorganism and only for the first episode. This risk was estimated for a period of 7 days from the date of the first positive blood culture using the Cox proportional hazards model [7] . CNS bloodstream infections were chosen as the reference category with five factors considered to be potential confounders: age (0 to 19, 20 to 39, 40 to 59, and 60 years or more); type of ward (medical us surgical); eight categories of disease defined by both anatomical site and histological type; geographical origin (France us other countries); and year of the first positive blood culture.
To study the ewlution of the risk of death throughout the 15 years under consideration (1 975 to 1989), this period was divided into two periods of similar duration (8 and 7 years, respectively): 1975 to 1982: and 1983 to 1989.
Trends in the incidence of bloodstream infections
The incidence of bloodstream infections increased fivefold between 1975 and 1989, ranging from 0.81 to 3.98 episodes per 1000 hospital-days. There was a marked increase in incidence between 1983 and 1986, followed by a plateau beginning in 1987. This was mainly observed in patients hospitalized in the medical wards during the study period (from 0.71 to 3.40 per 1000 hospital-days), and was less marked in the surgical wards. The trends in the incidence of episodes caused by the eight main microbial genera are shown in Figure 1 . The greatest increases were seen for episodes caused by CNS strains (from 0.06 to 2.48 per 1000 hospital-days), yeasts (from less than 0.001 to 0.1 per 1000 hospitaldays) and Staphylococcus auieus (from 0.005 to 0.04 per 1000 hospital-days). There was also a rise, albeit a lesser increase, in the incidence of episodes caused by members of the family Enterobacteriaceae (from 0.35 to 0.68 per 1000 hospital-days), Pseudomonadaceae (from 0.06 to 0.23 per 1000 hospital-days), streptococci (from 0.07 to 0.24 per 1000 hospital-days), enterococci (from 0.02 to 0.14 per 1000 hospital-days), and anaerobes (from 0.04 to 0.22 per 1000 hospital-days).
Risk of death according to six potential prognostic factors
As expected, the risk of death increased with age (Table  3) and decreased significantly for patients originating from a country other than France. Indeed, when foreign patients are critically ill, they often return to their native countries as an emergency. Although death was likely to have occurred quickly (before day 7) for many of these patients, no definite information was available for analysis. Thus, as this factor might introduce some bias into the analysis, this was considered to be a potential confounder. The risk of death was lower for patients hospitalized in surgical wards than for those in medical wards, which included intensive care units. Differences according to underlying disease were slight, but significant (p < 0.001; Table 3 ).
The overall risk of death at day 7 after the first episode of bloodstream infection caused by a single microorganism decreased by a significant 50% during the 15-year period under study. By contrast, the risk of death was not significantly different whether the episode was categorized as nosocomial or not.
Finally, only five factors (age, type of ward, underlying disease, geographical origin and year of first postive culture; Table 3 ) have been taken into account in all subsequent analyses.
Risk of death by type of microorganism
The risk of death associated with each type of microorganism is shown in Table 4 . The greatest risk Streptococcus species (RR = 2.1). The risks associated with anaerobes, miscellaneous gram-negative and grampositive bacteria as well as enterococci were not significantly different from those associated with CNS strains.
Risk of death according to number of positive blood cultures
The risk of death stratified by the microorganism was not statistically different whether the patient had single-or multiple-organism positive blood cultures (Table 5 ). In addition, the risks shown in Table 4 were not altered when the number of positive blood cultures was taken into consideration in the analyses.
Trends in mortality by type of microorganism
The overall risk of death decreased significantly during the 15-year study period according to both the univariate analysis (RR = 0.5, p < 0.001; Table 3 ) and the multivariate analysis (z, < 0.001; Table 6 ). A significant decrease in the risk of death was observed in patients with Pseudomonadaceae and with S. aureus infections, reaching an estimated 60%. This was of borderline significance for those with CNS infections. The risk of death was virtually constant for patients with infections caused by members of the family Enterobacteriaceae or by streptococci. The risk of death apparently increased markedly for infections caused by enterococci and decreased for those caused by yeasts. However, the variability in the risk of death associated with the various types of niicroorganisms during the study tinie period was only of borderline significance (p = 0.07; Table 6 ). 
DISCUSSION
The incidence of bloodstreani dramatically during the 15-year cularly in medical wards and for infections increased study period, partiinfections caused by CNS strains, yeasts and S. aureus. The highest risk of death was observed for patients with infection caused by pseudomonads, Enterobacteriaceae, S. aureus and yeasts. In addition, the risk of death decreased significantly over the study period for infections caused by S. auueus and pseudomonads. However, the variability among the different types of microorganisms in the evolution of risk of death associated with the time period was only of borderline significance.
Several workers have previously stressed the recent increase in the frequency of gram-positive infections, particularly those involving CNS strains and streptococci, both in the general population [8] and in cancer patients [9, 10] . The marked increase in CNS infections found in the present study was probably related to the increasingly frequent use of central venous catheters, as reported elsewhere [11, 12] . Our results indicate that this was not associated with a decrease in the prevalence of cases caused by either Enterobacteriaceae or Pseudonionadaceae, and conform with reports of the general hospital population [I 31.
An increased incidence of nosoconiial yeast bloodstream infections over the last 10 years has been reported in the United States [I 41. In the present study, at least part of the observed increase may have been due to change in the blood culture system used. Earlier studies have shown that several independent risk factors are significantly associated with the occurrence of yeast infections in cancer patients [I 5,161. The mortality associated in cancer patients with blood infections caused by a single bacterial species has been frequently studied [17-291, but variations in the incidence of such infections over a period of time and in the associated mortality have not been reported. Furthermore, the trends in nosocomial primary bloodstream infections in the US between 1980 and 1989 have been published, but no emphasis was placed on the associated mortality [8] .
High mortality rates were observed after infection in cancer patients by Pseudomonas species [ I 7,28,29] , members of the family Enterobacteriaceae [ 17, 20, 23, 25, 26] and yeasts 115,161. Other reports of the mortality associated with bloodstreani infections are either not recent [22, 31] or do not refer specifically to cancer patients or are limited to a short period of observation [37, 38] . However, in a 3-year study of positive blood cultures, the rates of mortality after bacteremic episodes caused by various microorganisrns were essentially the same as ours 1371, with the highest percentages following infections caused by yeasts, Pseudomonas species, S. aureus and menibers of the family Enterobacteriaceae 1371. Also, bloodstream infection with Pseudomonas aeuuginosa was an independent predictor of death in episodes of nosocomial infection [34] .
In the present study, the high frequency of CNS infections observed during recent years can be considered to be one of the factors accounting for the overall decrease in the risk of death. As already described, one feature of the present study was to include as case-patients all those with a single positive blood culture, including CNS infections. The likelihood that a single CNS-positive blood culture represents a true infection is reported to be low [39] . It niay be that the reason why mortality appears to be decreasing is that more clinically insignificant contaminants are being counted as infections. However, in the present study population, the risk of death was similar whether patients had one or several positive blood cultures (Table 5) , including CNS infections. Anyhow, CNS mortality data was used only as a baseline for comparison with other microbial groups.
The present study results for the risk of death may be debatable because only five potential confounders were considered. Several other factors, such as neutropenia, might have been included. However, data on neutrophil counts at the time of bacteremia were not available. In addition, to our knowledge, although neutropenia is a major risk factor for infection in cancer patients, it has not been reported to be related to the bacterial species involved. It is also debatable as to whether death was mainly due to the underlying disease. Our hypotheses were that: 1) the mortality attributable to cancer was equally distributed among all types of infection; and 2) the short duration (7 days) of the period of study further decreased this risk, as the clinical evolution of cancer is usually much slower than that of infection.
The decrease in the risk of death associated with S. uureus between 1975 and 1989 may be accounted for by the increasingly systematic early use of vancomycin during the 1980s in the IGR [ll], as has been previously recommended [9, 10] . The risk associated with members of the family Pseudomonadaceae has also decreased, which may be related to changes in the use of antibiotics.
During the 1970s and early 1980s, antimicrobials, such as carbenicillin, which have a relatively high minimum inhibitory concentration (MIC) against pseudomonads [40] were used. These drugs have been replaced by agents with lower MICs such as piperacillin, ceftazidime and thienamycin [40] , which became available in France in 1983, 1987 and 1986, respectively. Furthermore, most of the first-line enipirical therapy regimens currently in use include compounds such as ceftazidime or piperacillin, which are highly active against pseudomonads. This was not the case in the early 1980s, when second-generation cephalosporins or third-generation cefotaxime were commonly used. This may explain the decrease in associated mortality, as early initiation of appropriate antibiotic therapy has significantly reduced I? ueruginosu-associated mortality in patients with cancer [ 17) .
The same reasons might also explain why the mortality associated with Enterobacteriaceae bloodstream infections did not significantly drop, as antibiotics highly active against these bacteria, such as the second-generation cephalosporins and cefotaxime (since 1981), were already in use as first-line empirical therapy throughout the study period.
The present study results show that the mortality associated with bloodstream infections has decreased in cancer patients over the 15-year period studied, although the incidence of infections caused by most microbial species has risen. This decrease may be related to the better use of more effective antimicrobial agents and constitutes an argument in favor of continuation of the strict application of aggressive empirical antimicrobial therapy in the management of fever in cancer patients [lo] .
